CARE Ratings Launches SEBI-Approved Investor Verification Service May 4, 2026
CARE Ratings Limited will launch its new Past Risk and Return Verification Agency (PaRRVA) services on May 4, 2026, after receiving final authorization from India's market regulator, SEBI. The company received official recognition for this role on December 5, 2025, with SEBI issuing an authorization circular on April 29, 2026.
This development represents a significant diversification for CARE Ratings. The introduction of the PaRRVA service line taps into SEBI's initiative to improve investor protection and establishes a new revenue stream, potentially strengthening the company's financial performance and market position.
SEBI established the PaRRVA framework to standardize the verification of historical risk and return data for investment products. The goal is to provide investors with greater transparency and reliability when assessing products such as Alternative Investment Funds (AIFs) and mutual funds. CARE Ratings was among the entities chosen to pilot this program, helping to test and refine the operational aspects of these new verification services.
With this launch, CARE Ratings will expand its product suite beyond traditional credit ratings. This creates a new avenue for revenue generation. Investors and fund managers can now access standardized past risk and return verification from CARE Ratings, positioning the company as a key player in SEBI's enhanced investor protection ecosystem.
However, several factors will be critical to the service's success. These include market adoption by fund managers and investors, competition from other rating agencies offering similar PaRRVA services, and potential changes in the regulatory landscape for these services.
CARE Ratings operates in a competitive market alongside established players like CRISIL Ratings and ICRA Limited. While these peers are dominant in credit ratings, their entry into PaRRVA services will significantly influence competition in this new area.
Financially, CARE Ratings reported standalone revenue of approximately ₹660 crore in FY24. The company also posted a standalone Profit After Tax of approximately ₹250 crore in the same fiscal year.
Moving forward, key indicators to track will include the initial uptake and client wins for CARE Ratings' PaRRVA services, the revenue contribution from this new vertical in upcoming quarters, any competitive announcements, and further guidance from SEBI on the PaRRVA framework.
